14.06.2017
- US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...
14.04.2016
- Bristol-Myers Squibb’s cancer drug Opdivo can now be used to treat more patients with lung cancer or kidney cancer after European regulators expanded its indications. The EU...
